ABT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ABTAbbott Laboratories

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ABTAbbott Laboratories

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ABT

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.3%▼−1.89%×0.36

Q2 FY26±4.3%▲+10.71%×2.49

Q1 FY26±4.4%▼−6.00%×1.36

Jan 22 '26±3.2%▼−10.04%×3.13

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedABT realized, solidLLY realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ABTAbbott Laboratories

113.58· pre 111.81· delayed

Mkt cap$200.1BRevenue$13.0BQ3 FY26Revenue$44.3BFY25

LLYELI Lilly & Co

1,371.32· pre 1,348.39· delayed

Pre-marketNov 6 '26delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 6 '26delayed

ABTAbbott Laboratories

LLYELI Lilly & Co

113.58pre 111.81delayed

Price

1,371.32pre 1,348.39delayed

$200.1B

Mkt cap

$1.2T

Q3 FY26$13.0B

Revenue

$24.4BQ3 FY26

FY25$44.3B

Revenue

$65.2BFY25

ABT113.58vsLLY1,371.32Pre-marketNov 6 '26delayed